{"title":"中国药师人力资源的区域差异、分布动态与空间趋同——基于医疗层级差异的视角","authors":"Bo Ding, Run Zhao, Xinyi Yue, Dexun Li","doi":"10.2147/RMHP.S534923","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to analyze the regional and hierarchical disparities in the distribution of pharmacist human resources in China from 2012 to 2022, with the goal of identifying underlying trends and challenges. The findings are intended to serve as a basis for optimizing the equitable and efficient allocation of pharmacist resources to better support healthcare system development.</p><p><strong>Patients and methods: </strong>Data were collected from the China Health Statistics Yearbook and China Statistics Yearbook. The number of pharmacists per 1,000 population was selected as a measure of equity in pharmacist allocation, and Dagum's Gini coefficient, kernel density estimation method and spatial β-convergence model were utilized to analyze the regional differences and convergence trends of pharmacist resource allocation in Chinese hospitals and primary health care organizations.</p><p><strong>Results: </strong>The findings reveal that while the overall allocation of pharmacist resources has improved, significant discrepancies remain. The mean number of hospital pharmacists was approximately twice that of primary care centers, with the most pronounced disparity observed in the central region. Regional disparities show declining trends in hospitals but widening gaps in PHCs, particularly in the eastern region. Kernel density results highlight improvements in pharmacist distribution but also reinforce advantages for High-resource provinces, especially at the hospital tier. Spatial analysis indicates significant clustering effects in pharmacist allocation, though these effects have weakened over time. Notably, absolute and conditional β-convergence trends are observed, with faster convergence rates in hospitals compared to PHCs and distinct regional variations in convergence speed.</p><p><strong>Conclusion: </strong>Since 2012, the allocation of pharmacists' human resources in China has improved, with regional disparities showing signs of reduction. However, hierarchical disparities remain a significant issue that requires further attention, particularly in the central region. To address these challenges, it is essential to increase investment in primary healthcare institutions, with a focus on strengthening pharmacist staffing, improving infrastructure, and enhancing the capacity of pharmacy services at the grassroots level.</p>","PeriodicalId":56009,"journal":{"name":"Risk Management and Healthcare Policy","volume":"18 ","pages":"2769-2785"},"PeriodicalIF":2.0000,"publicationDate":"2025-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393082/pdf/","citationCount":"0","resultStr":"{\"title\":\"Regional Differences, Distributional Dynamics and Spatial Convergence of Pharmacist Human Resources in China: A Healthcare Tiers Difference Perspective.\",\"authors\":\"Bo Ding, Run Zhao, Xinyi Yue, Dexun Li\",\"doi\":\"10.2147/RMHP.S534923\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study aims to analyze the regional and hierarchical disparities in the distribution of pharmacist human resources in China from 2012 to 2022, with the goal of identifying underlying trends and challenges. The findings are intended to serve as a basis for optimizing the equitable and efficient allocation of pharmacist resources to better support healthcare system development.</p><p><strong>Patients and methods: </strong>Data were collected from the China Health Statistics Yearbook and China Statistics Yearbook. The number of pharmacists per 1,000 population was selected as a measure of equity in pharmacist allocation, and Dagum's Gini coefficient, kernel density estimation method and spatial β-convergence model were utilized to analyze the regional differences and convergence trends of pharmacist resource allocation in Chinese hospitals and primary health care organizations.</p><p><strong>Results: </strong>The findings reveal that while the overall allocation of pharmacist resources has improved, significant discrepancies remain. The mean number of hospital pharmacists was approximately twice that of primary care centers, with the most pronounced disparity observed in the central region. Regional disparities show declining trends in hospitals but widening gaps in PHCs, particularly in the eastern region. Kernel density results highlight improvements in pharmacist distribution but also reinforce advantages for High-resource provinces, especially at the hospital tier. Spatial analysis indicates significant clustering effects in pharmacist allocation, though these effects have weakened over time. Notably, absolute and conditional β-convergence trends are observed, with faster convergence rates in hospitals compared to PHCs and distinct regional variations in convergence speed.</p><p><strong>Conclusion: </strong>Since 2012, the allocation of pharmacists' human resources in China has improved, with regional disparities showing signs of reduction. However, hierarchical disparities remain a significant issue that requires further attention, particularly in the central region. To address these challenges, it is essential to increase investment in primary healthcare institutions, with a focus on strengthening pharmacist staffing, improving infrastructure, and enhancing the capacity of pharmacy services at the grassroots level.</p>\",\"PeriodicalId\":56009,\"journal\":{\"name\":\"Risk Management and Healthcare Policy\",\"volume\":\"18 \",\"pages\":\"2769-2785\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-08-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393082/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Risk Management and Healthcare Policy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/RMHP.S534923\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Risk Management and Healthcare Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/RMHP.S534923","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Regional Differences, Distributional Dynamics and Spatial Convergence of Pharmacist Human Resources in China: A Healthcare Tiers Difference Perspective.
Purpose: This study aims to analyze the regional and hierarchical disparities in the distribution of pharmacist human resources in China from 2012 to 2022, with the goal of identifying underlying trends and challenges. The findings are intended to serve as a basis for optimizing the equitable and efficient allocation of pharmacist resources to better support healthcare system development.
Patients and methods: Data were collected from the China Health Statistics Yearbook and China Statistics Yearbook. The number of pharmacists per 1,000 population was selected as a measure of equity in pharmacist allocation, and Dagum's Gini coefficient, kernel density estimation method and spatial β-convergence model were utilized to analyze the regional differences and convergence trends of pharmacist resource allocation in Chinese hospitals and primary health care organizations.
Results: The findings reveal that while the overall allocation of pharmacist resources has improved, significant discrepancies remain. The mean number of hospital pharmacists was approximately twice that of primary care centers, with the most pronounced disparity observed in the central region. Regional disparities show declining trends in hospitals but widening gaps in PHCs, particularly in the eastern region. Kernel density results highlight improvements in pharmacist distribution but also reinforce advantages for High-resource provinces, especially at the hospital tier. Spatial analysis indicates significant clustering effects in pharmacist allocation, though these effects have weakened over time. Notably, absolute and conditional β-convergence trends are observed, with faster convergence rates in hospitals compared to PHCs and distinct regional variations in convergence speed.
Conclusion: Since 2012, the allocation of pharmacists' human resources in China has improved, with regional disparities showing signs of reduction. However, hierarchical disparities remain a significant issue that requires further attention, particularly in the central region. To address these challenges, it is essential to increase investment in primary healthcare institutions, with a focus on strengthening pharmacist staffing, improving infrastructure, and enhancing the capacity of pharmacy services at the grassroots level.
期刊介绍:
Risk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of public health, policy and preventative measures to promote good health and improve morbidity and mortality in the population. Specific topics covered in the journal include:
Public and community health
Policy and law
Preventative and predictive healthcare
Risk and hazard management
Epidemiology, detection and screening
Lifestyle and diet modification
Vaccination and disease transmission/modification programs
Health and safety and occupational health
Healthcare services provision
Health literacy and education
Advertising and promotion of health issues
Health economic evaluations and resource management
Risk Management and Healthcare Policy focuses on human interventional and observational research. The journal welcomes submitted papers covering original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. Case reports will only be considered if they make a valuable and original contribution to the literature. The journal does not accept study protocols, animal-based or cell line-based studies.